Understanding how proteins interact with RNA
Protein Disorder as a Mechanism of RNA Binding and Regulation
This study is looking at how certain proteins that help control gene activity interact with RNA, which is important for understanding both healthy and disease conditions, and it could lead to new treatments for illnesses related to RNA processing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10897322 on NIH RePORTER |
What this research studies
This research investigates the interactions between RNA binding proteins (RBPs) and RNA, focusing on the role of disordered protein regions in these interactions. The study aims to uncover how these proteins, which are crucial for gene expression, bind to RNA in both normal and disease contexts. By employing biochemical methods and genomic strategies, the research seeks to clarify the mechanisms of RBP-RNA interactions and their implications for cellular function. Patients may benefit from insights gained into the regulation of gene expression and potential therapeutic targets for diseases linked to RNA processing.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals with genetic disorders or diseases that involve RNA processing abnormalities.
Not a fit: Patients with conditions unrelated to RNA processing or gene expression may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating diseases related to RNA processing and gene regulation.
How similar studies have performed: Other research has shown promising results in understanding RNA-protein interactions, suggesting that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Dominguez, Daniel Issac — Univ of North Carolina Chapel Hill
- Study coordinator: Dominguez, Daniel Issac
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.